Bill & Melinda Gates Foundation: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| Line 128: | Line 128: | ||
| first=T. | | first=T. | ||
| coauthors=Kurtz SE., Blauvelt A., Shimada S. | | coauthors=Kurtz SE., Blauvelt A., Shimada S. | ||
| | | date=2005, Dec. | ||
| title=The role of Langerhans cells in the sexual transmission of HIV. | | title=The role of Langerhans cells in the sexual transmission of HIV. | ||
| journal=J Dermatol Sci | | journal=J Dermatol Sci | ||
| Line 142: | Line 142: | ||
| first=L. | | first=L. | ||
| coauthors=Nabatov A., Pion M., Fluitsma D., de Jong MA., de Gruijl T., Piguet V., van Kooyk Y., Geijtenbeek TB. | | coauthors=Nabatov A., Pion M., Fluitsma D., de Jong MA., de Gruijl T., Piguet V., van Kooyk Y., Geijtenbeek TB. | ||
| | | date=2007, March | ||
| title=Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. | | title=Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. | ||
| journal=Nat Med | | journal=Nat Med | ||